Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 16Carcinoma, Non-Small-Cell Lung 7Ovarian Neoplasms 5Uterine Cervical Neoplasms 4Stomach Neoplasms 3Neoplasms 3Lung Neoplasms 3Endometrial Neoplasms 3Triple Negative Breast Neoplasms 2Pancreatic Intraductal Neoplasms 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Thrombosis 1Stage IA Uterine Sarcoma 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Solid Tumor Cancer 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Peripheral Nervous System Diseases 1Pancreatic Cyst 1Pain 1Organoid 1Neoplasms, Germ Cell and Embryonal 1NSCLC 1Motor Activity 1Medulloblastoma 1Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer 1

Interventions

Vinorelbine 1Probiotics 1Pemetrexed 1Paclitaxel 1Docetaxel 1Cisplatin 1Carboplatin 1Blood Specimen Collection 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinogenesis × Paclitaxel × Clear all
NCT01209520 2015-02-24

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

University of Miami

Phase NA Completed
6 enrolled 6 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinogenesis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡